ISPE Announces Recipients of 2014 International
Honor Awards at Global Annual Meeting
Download the Press Release ( 64 KB)
(TAMPA, FLA. USA, 20 October 2014) – ISPE announced the recipients of the 2014 International Honor Awards at the Society’s Annual Meeting in Las Vegas, NV, USA on 12 – 15 October. Recognizing the awardees’ contributions to ISPE and the pharmaceutical industry, ISPE President and CEO, John E. Bournas presented the honors on behalf of the ISPE Board of Directors.
“The 2014 International Honor Award winners exemplify the mission of ISPE and its commitment to pharmaceutical manufacturing and patient safety,” said Bournas. “Each recipient is dedicated to the sustainability of ISPE and to defining and sharing best practices in manufacturing, quality and compliance throughout the entire product lifecycle. We are grateful for their contributions to the society and the industry as a whole.”
The 2014 award winners are:
To read more about these Society leaders and the awards they received, and to view the complete list of awards presented at the 2014 ISPE Annual Meeting, please visit the ISPE International Honor Awards page on the ISPE website.
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA. Visit www.ISPE.org for more information.
For more information contact:
Associate Director, Marketing Communications, ISPE
Tel: +1-813-960-2105, ext. 309
Chairman Chatter: Embracing the Challenge
Tuesday, 20 Sep 2016 19.09
Women in Pharma Debuts at 2016 ISPE Annual Meeting & Expo
Tuesday, 20 Sep 2016 14.09
You’re All HEROES! Two Powerful Pharma Keynote Messages
Tuesday, 20 Sep 2016 02.09